Klarity - Weight Loss Looking for weight loss options? GLP-1 agonist medications, originally designed to manage type 2 ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient ... Both groups followed a reduced-calorie diet and exercise plan. Common side effects include nausea, diarrhea ...
14d
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback